Futu News, February 17, this Thursday $CLARITY MEDICAL (01406.HK)$The announcement announced that the company will issue 136 million shares, priced at HK$1.6 per share, and 1,250 shares per lot. It is expected to go public on February 18.
At the public sale stage, Clear Medical received 6.17 times more subscriptions. The final number of shares sold to the public sale was 13.6 million shares, accounting for about 10% of the total number of shares offered (before any over-allotment rights were exercised). A total of 8,642 valid applications were received. The first-hand winning rate was 40%, and the 8-hand subscription was stable.
Furthermore, the international offering has been slightly oversubscribed, and the final number of shares offered is approximately 122.4 million shares, equivalent to about 90% of the total number of shares offered (before any over-allotment rights are exercised). Futu News has compiled relevant data in the following table:
The company's net proceeds of approximately HK$177.3 million (assuming no over-allotment rights are exercised) will be used for the following purposes: 44.8% for the establishment of two new medical centres in Hong Kong, China to provide ophthalmology services; 30.5% for the acquisition of majority and/or minority interests in one or two eye clinics, ophthalmology clinics or eye hospitals in selected cities in the Greater Bay Area; 14.7% for the establishment of ophthalmology clinics in mainland China with suitable partners to provide ophthalmic services; and 10.0% for working capital and other general corporate purposes.
Clarity Medical is a private medical institution that specializes in ophthalmology. It provides medical treatment at Hong Kong Central Medical Centre and Mongkok...